These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24340285)

  • 21. Endocrine and metabolic effects of long-term administration of [Nle27]growth hormone-releasing hormone-(1-29)-NH2 in age-advanced men and women.
    Khorram O; Laughlin GA; Yen SS
    J Clin Endocrinol Metab; 1997 May; 82(5):1472-9. PubMed ID: 9141536
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IGF-1 Levels are Inversely Associated With Metabolic Syndrome in Obstructive Sleep Apnea.
    Izumi S; Ribeiro-Filho FF; Carneiro G; Togeiro SM; Tufik S; Zanella MT
    J Clin Sleep Med; 2016 Apr; 12(4):487-93. PubMed ID: 26612512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum free and total insulin-like growth factor-I, insulin-like growth factor binding protein-1 and insulin-like growth factor binding protein-3 Levels in healthy elderly individuals. Relation to self-reported quality of health and disability.
    Janssen JA; Stolk RP; Pols HA; Grobbee DE; Lamberts SW
    Gerontology; 1998; 44(5):277-80. PubMed ID: 9693259
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin-like Growth Factor-1 and IGF Binding Proteins Predict All-Cause Mortality and Morbidity in Older Adults.
    Zhang WB; Aleksic S; Gao T; Weiss EF; Demetriou E; Verghese J; Holtzer R; Barzilai N; Milman S
    Cells; 2020 Jun; 9(6):. PubMed ID: 32492897
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women.
    Söderberg S; Ahrén B; Eliasson M; Dinesen B; Brismar K; Olsson T
    Eur J Endocrinol; 2001 Mar; 144(3):283-90. PubMed ID: 11248749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Determinants of serum insulin-like growth factor I in growth hormone deficient adults as compared to healthy subjects.
    Jørgensen JO; Vahl N; Hansen TB; Skjaerbaek C; Fisker S; Orskov H; Hagen C; Christiansen JS
    Clin Endocrinol (Oxf); 1998 Apr; 48(4):479-86. PubMed ID: 9640415
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changes in serum concentrations of growth hormone, insulin, insulin-like growth factor and insulin-like growth factor-binding proteins 1 and 3 and urinary growth hormone excretion during the menstrual cycle.
    Juul A; Scheike T; Pedersen AT; Main KM; Andersson AM; Pedersen LM; Skakkebaek NE
    Hum Reprod; 1997 Oct; 12(10):2123-8. PubMed ID: 9402266
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Animal protein intakes during early life and adolescence differ in their relation to the growth hormone-insulin-like-growth-factor axis in young adulthood.
    Joslowski G; Remer T; Assmann KE; Krupp D; Cheng G; Garnett SP; Kroke A; Wudy SA; Günther AL; Buyken AE
    J Nutr; 2013 Jul; 143(7):1147-54. PubMed ID: 23700336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The study of spontaneous GH secretion after 36-h fasting distinguishes between GH-deficient and normal adults.
    Aimaretti G; Colao A; Corneli G; Pivonello R; MacCario M; Morrison K; Pflaum CD; Strasburger CJ; Lombardi G; Ghigo E
    Clin Endocrinol (Oxf); 1999 Dec; 51(6):771-7. PubMed ID: 10619983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
    Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
    J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of estradiol and exogenous insulin-like growth factor I (IGF-I) on the IGF-I axis during growth hormone inhibition and antagonism.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Nov; 83(11):4013-21. PubMed ID: 9814485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of oral versus transdermal estrogen on the growth hormone/insulin-like growth factor I axis in younger and older postmenopausal women: a clinical research center study.
    Bellantoni MF; Vittone J; Campfield AT; Bass KM; Harman SM; Blackman MR
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2848-53. PubMed ID: 8768841
    [TBL] [Abstract][Full Text] [Related]  

  • 34. No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes.
    Dall R; Lange KH; Kjaer M; Jørgensen JO; Christiansen JS; Orskov H; Flyvbjerg A
    J Clin Endocrinol Metab; 2001 Feb; 86(2):669-74. PubMed ID: 11158029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
    Lassarre C; Duron F; Binoux M
    J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decline in circulating insulin-like growth factors and mortality in older adults: cardiovascular health study all-stars study.
    Kaplan RC; Bùzková P; Cappola AR; Strickler HD; McGinn AP; Mercer LD; Arnold AM; Pollak MN; Newman AB
    J Clin Endocrinol Metab; 2012 Jun; 97(6):1970-6. PubMed ID: 22442270
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.
    de Groof F; Joosten KF; Janssen JA; de Kleijn ED; Hazelzet JA; Hop WC; Uitterlinden P; van Doorn J; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3118-24. PubMed ID: 12107211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin-like growth factor I, insulin-like growth factor binding protein 3, and atrial fibrillation in the elderly.
    Duron E; Vidal JS; Funalot B; Brunel N; Viollet C; Seux ML; Treluyer JM; Epelbaum J; Bouc YL; Hanon O
    J Gerontol A Biol Sci Med Sci; 2014 Aug; 69(8):1025-32. PubMed ID: 24368776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating levels of insulin-like growth factor (IGF) binding protein-1 and -3 in aging men: relationships to insulin, glucose, IGF, and dehydroepiandrosterone sulfate levels and anthropometric measures.
    Benbassat CA; Maki KC; Unterman TG
    J Clin Endocrinol Metab; 1997 May; 82(5):1484-91. PubMed ID: 9141538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
    Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
    Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.